Already studies have shown that the Wnt/ β-catenin pathway attenuates experimental emphysema [68] and the Wnt inhibitor SFRP-1 up regulates the expression of proteases that are important in the development of human emphysema [69]. The gene discussed is SFRP1; the disease is pulmonary emphysema.